期刊文献+

乳腺癌组织中MMP-2、TIMP-2、TGF-β_1、TGF-β_1RⅠ的表达及相关性分析 被引量:6

Expression of MMP-2,TIMP-2,TGF-β_1,TGF-β_1RI and its relationship in breast cancer
下载PDF
导出
摘要 目的探讨基质金属蛋白酶(MMP)-2及其抑制物(TIMP-2)与转化生长因子(TGF)-β1及其I型受体(TGF-β1RI)在乳腺癌组织中的表达及其相关性。方法应用免疫组化SP法检测80例乳腺癌组织中的MMP-2、TIMP-2与TGF-β1、TGF-β1RI蛋白。结果乳腺癌中MMP-2、TIMP-2、TGF-β1和TGF-β1RI阳性表达率分别为67.5%、45.0%、80.0%和67.5%;无淋巴结转移者MMP-2、TIMP-2阳性表达率为44.4%、66.7%,与转移淋巴结个数1~3(85.7%、21.4%)、>3个(87.5%、37.5%)相比,P均<0.01;TNM分期为Ⅰ期的MMP-2、TIMP-2阳性表达率分别为0、75%,分别与Ⅱ(65.0%、55.0%)、Ⅲ(86.7%、26.7%)、Ⅳ期(100%、0)相比,P均<0.05;肿瘤直径≤2cm者TIMP-2阳性表达率为66.7%,与直径2~5(51.9%)、>5cm(20.0%)相比,P均<0.05;MMP-2和TGF-β1的表达呈正相关(r=0.454,P<0.01),MMP-2和TGF-β1RI的表达呈负相关(r=-0.481,P<0.01)。结论MMP-2和TIMP-2的表达情况与乳腺癌侵袭转移有密切关系。MMP-2的表达与TGF-β1、TGF-β1RI关系密切,MMP-2可能在一定程度上受到TGF-β及其受体的调控。 Objective To investigate the expression of MMP-2, TIMP-2, TGF-β1 and TGF-β1 RⅠ, its relationship in breast cancer. Methods The MMP-2, TIMP-2, TGF-β1 and TGF-β1 RⅠ were examinated in 80 cases of breast carcinoma by SP immunohistochemical method. Results The positive rates of MMP-2, TIMP-2, TGF-β1 and TGF-β1RⅠ were 67. 5% ,45.0% ,80.0% and 67.5%, respectively. The expression of MMP-2 was positively correlated to axillary lymph node metastasis and TNM staging( P 〈0.01 and P 〈0. 01, respectively). The expression of TIMP-2 was positively correlated to tumor size, axillary lymph node metastasis ( P 〈 0. 05, P 〈 0.01, respectively). The expression of MMP-2 was positively correlated to that of TGF-β1 ( r = 0. 454, P 〈 0. 01 ) , and was negatively correlated to that of TGF-β1 RⅠ ( r = - 0.481, P 〈 0.01 ). Conclusions The expression of MMP-2 and TIMP-2 might be close correlated to the invasion and metastasis of breast cancer. The expression of MMP-9 has a close relationship with TGF-β1 and TGF-β1 RⅠ. The levels of MMP-9 might be partly regulated by TGF-β1 and TGF-β1RⅠ.
机构地区 安徽医科大学
出处 《山东医药》 CAS 北大核心 2008年第24期12-14,共3页 Shandong Medical Journal
基金 安徽省高等学校青年教师科研项目(2007-J-1076) 安徽医科大学校科研基金资助项目(2006kj03)
关键词 乳腺肿瘤 基质金属蛋白酶2 基质金属蛋白酶2组织抑制剂 转化生长因子Β1 转化生长因子母β1Ⅰ型受体 breast neoplasms metrix metalloproteinase-2 tissue inhibitor of metalloproteinase-2 transforming growing factorβ1 type Ⅰ of transforming growing factorβ1
  • 相关文献

参考文献2

二级参考文献8

  • 1龚涌灵 许国铭.人胰腺癌中细胞外基质蛋白的分子生物学意义[J].国外医学:肿瘤学分册,1997,:270-270.
  • 2Warana JL,Attisano L,Wieser R.Mechanism of activation of theTGF-beta receptor[].Nature.1994
  • 3Eisma RJ,Spiro JD,Biberstein SE,et al.Decreased expression of transforming growth factor-βreceptors on head and neck squamous carcinoma cells[].The American Journal of Surgery.1996
  • 4Marrogi AJ,Munshi A,Merogi AJ,et al.Study of tumorinfiltrating lymphocytes and transforming growth factor-beta as prognostic factors in breast carcinoma[].International Journal of Cancer.1997
  • 5Murra PA,Burret LP,Travers M,et al.The prognosticsignificance of transforming growth factors in human breast cancer[].British Journal of Cancer.1993
  • 6Markowitz S,Wang J,Myeroff L,et al.Inactivation of the type II TGF-beta receptor in colon cancer cells with micro-satellite instability[].Science.1995
  • 7Cardillo MR,Yap E,Cstagna G.Molecular genetic analysis of TGFβ1 in breast cancer[].J Exp Lin Res.1997
  • 8Massague J.Receptor for the TGFβ1 family[].Cell.1992

共引文献26

同被引文献57

  • 1牛坚,陈澍周,钱海鑫.TGF-β1和MMP-2在胆囊癌中表达及临床意义[J].肿瘤防治杂志,2005,12(9):686-689. 被引量:3
  • 2姚建国(综述),陈莉(审校).乳腺癌还氧合酶-2表达的研究现状[J].国际肿瘤学杂志,2007,34(5):359-361. 被引量:1
  • 3Heider KH,Kut han H,Stehle G,et al.CD44v6:a target for antibody-based cancer therapy.Cancer immunol Immunother,2004,53:567-579.
  • 4Nakopoulou L,Tsirmpa I,Alexandrou P,et al.MMP-2protein in invasive breast cancer and the impact of MMP-2/TIMP-2phenotype on overall surviva1.Breast Cancer Res Treat,2003,77:145-155.
  • 5Saad RS,Kordunsky L,Liu YL,et al.Lymphatic microvessel density as prognostic marker in colorectal cancer.Mod Pathol,2006,19:1317-1323.
  • 6Jemal A,Siegel R,Xu J,et al. Cancer statistics. CA Cancer J Clin,2010,60:277-300.
  • 7Dumitrescu RG, Cotarla I. Understanding breast cancer risk-where dowestand in 2005. J CellMol Med,2005,9 :208-221.
  • 8Monig SP,Baldus SE,Hennecken JK,et al. Expression of MMP-2 associ-ated with progression and lymph node metastasis of gastric carcinoma.Histopathology ,2001,39 :597-602.
  • 9Fang J, Shing Y, Wiederschain D,et al. Matrix metalloproteinase-2 is re-quired for the switch to the angiagenic phenotype in a tumor model. ProcNatl Acad Sci USA,2000,97:3884.
  • 10Vilalta A, Sahuquillo J, Poca MA. Matrix metaloproteinases in neu-rologi-calbrain lesions: a new therapeutic target. Rev Neurol, 2010, 51 : 95-107.

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部